Easton Pharmaceuticals Inc (PINK:EAPH) lost its solid ground unexpectedly. After a huge gain last week, yesterday the stock started 
falling down and lost approximately 6% of its price. However, the most interesting fact here was that the loss happened despite promotions.
According to historical records, EAPH has been intensively promoted over the past two months and yesterday the campaign continued. The promoters claimed that Easton should be certainly placed on traders’ watchlists as its products targeted billion-dollar markets. Only this month, these alerts cost $15.000 so far, and they immediately influenced EAPH stock price. Though, it seems that the present promotions are not enough to hold the climb for longer.
Actually, even the positive news by Easton is not able to pump up the stock price at this point. The announcement was released this morning, reporting that the company has retained a Mexican regulatory consultancy to begin the process of submitting applications to obtain regulatory approvals for its first product.
Most probably, the good news is another company’s effort to get the up move again, giving new hopes to investors. In any case, now Easton is looking desperate to start soaring again.[BANNER]
However, while the promotions are pumping up EAPH, its financials are not inspiring at all. According to its 10-Q, the company’s total assets are not much higher than its liabilities, while the accumulated deficit went over $36 million.
Besides, Easton does not have significant cash or other material assets, nor does it have an established source of revenues sufficient to cover its operating costs.
In this case, it seems that the only hope for EAPH to escape from the going concern status is to release its first product successfully.
